Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome
Br J Haematol
.
2024 May 3.
doi: 10.1111/bjh.19500.
Online ahead of print.
Authors
Dong Hyun Kim
1
,
Junshik Hong
1
2
3
4
,
Dong-Yeop Shin
1
2
3
4
,
Inho Kim
1
2
,
Sung-Soo Yoon
1
2
3
4
,
Soo Mee Bang
5
,
Jeong-Ok Lee
5
,
Ji Yun Lee
5
,
Sang-A Kim
5
,
Ja Min Byun
1
3
,
Youngil Koh
1
2
3
4
Affiliations
1
Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
2
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
3
Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
4
Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea.
5
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
PMID:
38699798
DOI:
10.1111/bjh.19500
No abstract available
Publication types
Letter